|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kan WL, Yin C, Xu HX, Xu G, To KK, Cho CH,
Rudd JA and Lin G: Antitumor effects of novel compound, guttiferone
K, on colon cancer by p21Waf1/Cip1-mediated
G0/G1 cell cycle arrest and apoptosis. Int J
Cancer. 132:707–716. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A:
Colorectal cancer mortality rates in adults aged 20 to 54 years in
the United States, 1970–2014. JAMA. 318:572–574. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rampino N, Yamamoto H, Ionov Y, Li Y,
Sawai H, Reed JC and Perucho M: Somatic frameshift mutations in the
BAX gene in colon cancers of the microsatellite mutator
phenotype. Science. 275:967–969. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Yu J, Park BH, Kinzler KW and
Vogelstein B: Role of BAX in the apoptotic response to
anticancer agents. Science. 290:989–992. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haneef J, Parvathy M, Thankayyan RS,
Sithul H and Sreeharshan S: Bax translocation mediated
mitochondrial apoptosis and caspase dependent photosensitizing
effect of Ficus religiosa on cancer cells. PLoS One.
7:e400552012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhu S, Li T, Tan J, Yan X, Zhang D, Zheng
C, Chen Y, Xiang Z and Cui H: Bax is essential for death
receptor-mediated apoptosis in human colon cancer cells. Cancer
Biother Radiopharm. 27:577–581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li T, Liu X, Jiang L, Manfredi J, Zha S
and Gu W: Loss of p53-mediated cell-cycle arrest, senescence and
apoptosis promotes genomic instability and premature aging.
Oncotarget. 7:11838–11849. 2016.PubMed/NCBI
|
|
10
|
McCurrach ME, Connor TM, Knudson CM,
Korsmeyer SJ and Lowe SW: bax-deficiency promotes drug
resistance and oncogenic transformation by attenuating
p53-dependent apoptosis. Proc Natl Acad Sci USA. 94:2345–2349.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chittenden T, Flemington C, Houghton AB,
Ebb RG, Gallo GJ, Elangovan B, Chinnadurai G and Lutz RJ: A
conserved domain in Bak, distinct from BH1 and BH2, mediates cell
death and protein binding functions. EMBO J. 14:5589–5596. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferrer PE, Frederick P, Gulbis JM, Dewson
G and Kluck RM: Translocation of a Bak C-terminus mutant from
cytosol to mitochondria to mediate cytochrome c release:
Implications for Bak and Bax apoptotic function. PLoS One.
7:e315102012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gahl RF, He Y, Yu S and Tjandra N:
Conformational rearrangements in the pro-apoptotic protein, Bax, as
it inserts into mitochondria: A cellular death switch. J Biol Chem.
289:32871–32882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrika BB, Maney SK, Lekshmi SU, Joseph
J, Seervi M, K S P and T R S: Bax deficiency mediated drug
resistance can be reversed by endoplasmic reticulum stress induced
death signaling. Biochem Pharmacol. 79:1589–1599. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cunningham KG, Manson W, Spring FS and
Hutchinson SA: Cordycepin, a metabolic product isolated from
cultures of Cordyceps militaris (Linn.) link. Nature. 166:9491950.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jagger DV, Kredich NM and Guarino AJ:
Inhibition of Ehrlich mouse ascites tumor growth by cordycepin.
Cancer Res. 21:216–220. 1961.PubMed/NCBI
|
|
17
|
Kondrashov A, Meijer HA, Barthet-Barateig
A, Parker HN, Khurshid A, Tessier S, Sicard M, Knox AJ, Pang L and
De Moor CH: Inhibition of polyadenylation reduces inflammatory gene
induction. RNA. 18:2236–2250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakamura K, Yoshikawa N, Yamaguchi Y,
Kagota S, Shinozuka K and Kunitomo M: Antitumor effect of
cordycepin (3′-deoxyadenosine) on mouse melanoma and lung carcinoma
cells involves adenosine A3 receptor stimulation. Anticancer Res.
26:43–47. 2006.PubMed/NCBI
|
|
19
|
Choi KS: Autophagy and cancer. Exp Mol
Med. 44:109–120. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tao X, Ning Y, Zhao X and Pan T: The
effects of cordycepin on the cell proliferation, migration and
apoptosis in human lung cancer cell lines A549 and NCI-H460. J
Pharm Pharmacol. 68:901–911. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chaicharoenaudomrung N, Jaroonwitchawan T
and Noisa P: Cordycepin induces apoptotic cell death of human brain
cancer through the modulation of autophagy. Toxicol In Vitro.
46:113–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao HL, Liu ZJ and Chang Z: Cordycepin
induces apoptosis in human bladder cancer cells via activation of
A3 adenosine receptors. Tumour Biol. 39:10104283177069152017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hwang JH, Park SJ, Ko WG, Kang SM, Lee DB,
Bang J, Park BJ, Wee CB, Kim DJ, Jang IS, et al: Cordycepin induces
human lung cancer cell apoptosis by inhibiting nitric oxide
mediated ERK/Slug signaling pathway. Am J Cancer Res. 7:417–432.
2017.PubMed/NCBI
|
|
24
|
An WG, Hwang SG, Trepel JB and
Blagosklonny MV: Protease inhibitor-induced apoptosis: Accumulation
of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent
markers of proteasome inhibition. Leukemia. 14:1276–1283. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li SZ, Zeng F, Li J, Shu QP, Zhang HH, Xu
J, Ren JW, Zhang XD, Song XM and Du RL: Nemo-like kinase (NLK)
primes colorectal cancer progression by releasing the E2F1 complex
from HDAC1. Cancer Lett. 431:43–53. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Giorgi F, Lartigue L, Bauer MK,
Schubert A, Grimm S, Hanson GT, Remington SJ, Youle RJ and Ichas F:
The permeability transition pore signals apoptosis by directing Bax
translocation and multimerization. FASEB J. 16:607–609. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gotz C and Montenarh M: P53 and its
implication in apoptosis (Review). Int J Oncol. 6:1129–1135.
1995.PubMed/NCBI
|
|
28
|
Choisy-Rossi C, Reisdorf P and
Yonish-Rouach E: Mechanisms of p53-induced apoptosis: In search of
genes which are regulated during p53-mediated cell death. Toxicol
Lett. 102–103. 491–496. 1998.
|
|
29
|
Peña-Blanco A and García-Sáez AJ: Bax, Bak
and beyond-mitochondrial performance in apoptosis. FEBS J.
285:416–431. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto T, Yamada A, Yoshimura Y, Terada
H and Shinohara Y: The mechanisms of the release of cytochrome
c from mitochondria revealed by proteomics analysis.
Yakugaku Zasshi. 132:1099–1104. 2012.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tarangelo A and Dixon S: The p53-p21
pathway inhibits ferroptosis during metabolic stress. Oncotarget.
9:24572–24573. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Liu YY, Yang XF, Shen DF, Sun HZ,
Huang KQ and Zheng HC: Effects and mechanism of STAT3 silencing on
the growth and apoptosis of colorectal cancer cells. Oncol Lett.
16:5575–5582. 2018.PubMed/NCBI
|
|
33
|
Blankenberg FG: Apoptosis imaging:
Anticancer agents in medicinal chemistry. Anticancer Agents Med
Chem. 9:944–951. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hardwick JM and Soane L: Multiple
functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol.
5:a0087222013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zheng ZL, Qiu XH and Han RC:
Identification of the genes involved in the fruiting body
production and cordycepin formation of Cordyceps militaris
fungus. Mycobiology. 43:37–42. 2015. View Article : Google Scholar : PubMed/NCBI
|
